NCT03415750View on ClinicalTrials.gov

Everolimus and Tacrolimus Combination for Regression of Left Ventricular Hypertrophy in Renal Transplants

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

May 31, 2020

Study Completion Date

May 31, 2020

Conditions
Hypertrophy, Left Ventricular
Interventions
DRUG

Everolimus

Conversion from Mycophenolate mofetil to Everolimus

DRUG

Mycophenolate mofetil

Patients will remain in Tacrolimus + Mycophenolate mofetil

DRUG

Tacrolimus

Trial Locations (1)

08907

Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat

All Listed Sponsors
lead

Edoardo Melilli

OTHER

NCT03415750 - Everolimus and Tacrolimus Combination for Regression of Left Ventricular Hypertrophy in Renal Transplants | Biotech Hunter | Biotech Hunter